Is Fisher & Paykel Healthcare a good stock to buy?

Over half a decade, Fisher & Paykel Healthcare managed to grow its earnings per share at 4.4% a year. This EPS growth is slower than the share price growth of 13% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago.

Who is Fisher & Paykel?

Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. The single greatest medical breakthrough of all time? We are on the cusp of a medical breakthrough.

Where does Fisher & co make its money?

The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.